Back to search

CpG ODN is safe and highly effective in humans as adjuvant to HBV vaccine Preliminary results of phase I trial with CpG ODN 7909

Jenny Heathcote, D. Kaznowski, Christopher L. Cooper, Mary L. Morris, Sue M Elfer

Data up to Jan 2025

Published2000
Citations16
References0
Fields
MedicineBiologyImmunologyVirologyGenetics

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
CpG ODN is safe and highly effective in humans as adjuvant to HBV vaccine Preliminary… (2000) | Metascience Observatory Explorer